Investigational Site Number : 724001

Madrid 28050

0 studies enrolling now · 6 studies all time

What they study most

Cancer, Diffuse Large B-cell Lymphoma, Neoplasm Malignant, Ovarian Cancer Recurrent, Sarcoma, Sphingomyelin Lipidosis, Venous Thromboembolism

Studies at this site

• Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency — Completed
• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
• First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor — Completed
• A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies — Completed
• Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed